We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300059:SZSEEast Money Information Co., Ltd Class A Analysis

Data as of 2026-03-14 - not real-time

CN¥21.10

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

East Money is trading at CNY 21.1, barely above the computed support of 20.95 and well below its 20‑day SMA of 22.01, signaling short‑term pressure. Technical gauges reinforce a bearish outlook: the 14‑day RSI sits at 34, the MACD histogram is negative and the trend direction is flagged as bearish, while volume is increasing, suggesting accumulation but not enough to lift price. Fundamentally, the stock carries a forward PE of 23.9 versus an industry average of 16.35, indicating it is priced above peers, and its debt‑to‑equity ratio exceeds 145%, raising concerns about balance‑sheet resilience despite impressive gross (96%) and operating (72%) margins. The dividend yield is modest at 0.28% with a low payout ratio, yet operating cash flow is negative, casting doubt on the sustainability of any payout. Analyst sentiment remains positive, with a median target of CNY 33.35 and a consensus “buy”, implying a perceived upside of over 50% from current levels. In this mixed environment, investors must weigh the attractive margins and growth narrative against the elevated valuation, heavy leverage, and regulatory headwinds in China’s capital‑markets sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support
  • Bearish MACD and RSI indicating limited upside
  • Increasing volume but no clear breakout

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus “buy” with median target +50% upside
  • Strong gross and operating margins supporting earnings growth
  • Market positioning in fast‑growing fintech and wealth‑management services

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio and negative operating cash flow
  • Elevated regulatory scrutiny in China’s capital‑markets sector
  • Valuation premium relative to industry peers

Key Metrics & Analysis

Financial Health

Revenue Growth100.10%
Profit Margin80.36%
P/E Ratio26.4
ROE15.28%
ROA3.58%
Debt/Equity145.36
P/B Ratio3.8
Op. Cash FlowCN¥-26118248448
Industry P/E16.4

Technical Analysis

TrendBearish
RSI34.1
SupportCN¥20.95
ResistanceCN¥23.09
MA 20CN¥22.01
MA 50CN¥22.94
MA 200CN¥23.89
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target PriceCN¥31.99
Upside/Downside51.61%
GradeOvervalued
TypeGrowth
Dividend Yield0.28%

Risk Assessment

Beta0.13
Volatility19.44%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.